HASHEM EL-SERAG to Randomized Controlled Trials as Topic
This is a "connection" page, showing publications HASHEM EL-SERAG has written about Randomized Controlled Trials as Topic.
Connection Strength
0.515
-
A cluster randomized trial of a Multicomponent Clinical Care Pathway (MCCP) to improve MASLD diagnosis and management in primary care: study protocol. BMC Health Serv Res. 2025 May 06; 25(1):645.
Score: 0.170
-
Chemoprevention of Barrett's oesophagus: a step closer with PPIs and aspirin. Nat Rev Clin Oncol. 2018 12; 15(12):728-730.
Score: 0.109
-
Systematic review: persistent reflux symptoms on proton pump inhibitor therapy in primary care and community studies. Aliment Pharmacol Ther. 2010 Sep; 32(6):720-37.
Score: 0.061
-
Epidemiology, screening, diagnosis and treatment of hepatocellular carcinoma. Minerva Gastroenterol Dietol. 2009 Jun; 55(2):123-38.
Score: 0.056
-
Meta-analysis: the efficacy of over-the-counter gastro-oesophageal reflux disease therapies. Aliment Pharmacol Ther. 2007 Jan 15; 25(2):143-53.
Score: 0.048
-
Health-related quality of life in functional dyspepsia. Aliment Pharmacol Ther. 2003 Aug 15; 18(4):387-93.
Score: 0.038
-
Interferon: benefit beyond hepatitis therapy? Am J Gastroenterol. 2001 Dec; 96(12):3435-6.
Score: 0.033